The global bioresorbable
polymers market is anticipated to expand at a CAGR of 12.0% during the forecast
period of 2022-2030.
Bioresorbable polymers are advanced technological materials that can be broken
down and absorbed in the body fluids after performing the necessary actions,
such as to release controlled drugs inside the body or to support an organ
after surgery. These polymers don’t require any mechanical removal; however,
they are removed from the body via excretion, dissolution, or assimilation via
Bioresorbable polymers, due to their high performance and
biocompatibility, are widely used in the medical industry in applications such
as: wound management, orthopedic devices, drug delivery, cardiovascular
devices, and dental implants.
primarily driving the growth of this market include: the burgeoning usage of bioresorbable
polymers for various applications in the medical industry; the growing number
of surgical interventions; the surging demand for biocompatible medical devices;
the rising demand and usage of bioresorbable polymers as capsules in the drug
delivery application; and the escalating efforts by governments to upgrade
their healthcare sector.
in the body post-surgery pose several health risks to patients and also require
other minor surgery for their removal. On the other hand, bioresorbable
polymers disintegrate into the body over time and, as a result, eliminate all
the risks and threats as any second surgery for removing temporary implants is
not required. This increase in patient comfort offered by bioresorbable
polymers is expected to expand their market considerably in the forthcoming
advent of new and advanced technologies is expected to bring about tremendous
growth opportunities for the global bioresorbable polymers market. One such
development is the incorporation of 3D printing. Specific patients require specific
treatments in different circumstances. The slight differentiations required in
bioresorbable polymers are incorporated more reliably and efficiently with 3D
printing. Thus, the incorporation of 3D
printing is expected to boost the growth of the overall bioresorbable polymers
market in the next few years i.e., during the forecast period of 2022-2030.
other factors such as: the increasing production of environmentally friendly
products to meet the regulatory standards set by various environment protection
agencies; the soaring awareness among patients; the increasing disposable
income of consumers in matured countries; and the existence of favorable
reimbursement scenarios are expected to further augment the growth of the
global bioresorbable polymers market during the forecast period.
factors such as the high cost of bioresorbable polymers as compared to
conventional medical polymers, the increasing preference for minimally invasive
surgeries, and the dearth of reliable quality control and skilled personnel for
the effective use of medical products in emerging nations are expected to
restrict the growth of the global
Bioresorbable Polymers Market Segmentation:
Polylactic acid (PLA)
Poly (l-lactic) acid (PLLA)
-Poly-d,l-lactic acid (PDLLA)
Polyglycolic acid (PGA)
Middle East and Africa
Based on type, the
polylactic acid (PLA) segment led the global bioresorbable polymers market in
2021. The segment is predicted to maintain its dominance further in the market
during the forecast period of 2022-2030. However, the poly(lactic-co-glycolic
acid) (PLGA) segment is anticipated to attain the highest CAGR in the market
during the forecast period of 2022-2030. The growing preference for PLGA type of
polymers in drug delivery due to its biodegradability and biocompatibility is
the major factor ascribed to the large share and growth of this segment.
application, the orthopedic devices segment captured the largest share of the
global bioresorbable polymers market in 2021, followed by the drug delivery
segment. The segment is estimated to retain its lead further in the market
during the forecast period. The high incidence of orthopedic disorders across
the globe is the major reason behind the large share of this particular
The North American region acquired the largest share of
the global bioresorbable polymers market in 2021, followed by Europe and the Asia
Pacific. The region is likely to continue with its dominance further in the
market through the forecast period. Factors including but not limited to: the
rising demand for bioresorbable polymers; the presence of well-established
market players; the escalating innovations for the development of novel
biocompatible polymers with a broad range of physical and degradation
characteristics; the high level of technological sophistication in the
healthcare sector; and the surging R&D activities in the medical industry
are predominantly driving the growth of the bioresorbable market in this
region. The U.S. and Canada stand as the major contributors to the growth of
the market in the region.
The European region accounted for the second-largest
share of the global bioresorbable polymers market in 2021. The region is
projected to retain its position further in the market during the forecast
period on account of factors such as the ever-increasing geriatric population;
the increasing volume of surgeries; the existence of advanced healthcare infrastructure;
the high incidence of chronic diseases and neurological disorders; and the presence
of marquee players in the region. France, Germany, Russia, the U.K., and Italy are
the major contributors to the growth of the market in the region.
The Asia Pacific region held the third-largest share in
the global bioresorbable polymers market in 2021. The region is poised to
emerge as the fastest-growing regional market for bioresorbable polymers during
the forecast period. The growth of the market in the region can be attributed
to the proliferating demand for bioresorbable polymers in the expanding
healthcare industries in emerging nations; the growing number of hospitals; the
increasing number of supportive reimbursement policies; the rising investments
in the healthcare industry; and the surging consumer awareness in the region.
Additionally, the growing disposable income of people; and the rising geriatric
population in the region are also significantly adding to the growth of the
bioresorbable polymers market in the region. India and China are the leading
contributors to the growth of the market in the region.
Key Companies in Bioresorbable Polymers Market:
Zeus Industrial Products Inc.
REVA Medical LLC
Evonik Industries AG
Huizhou Foryou Medical Devices Co. Ltd.
Musashino Chemical Laboratory Ltd.
Henan Xinghan Biotechnology Co. Ltd.
DSM Biomedical Inc.
Ashland Global Holdings Inc.
Bezwada Biomedical LLC
Nomisma Healthcare Pvt. Ltd.